GoHealth, Inc. (GOCO)

NASDAQ: GOCO · Real-Time Price · USD
5.60
+0.14 (2.56%)
At close: Jun 18, 2025, 4:00 PM
5.75
+0.15 (2.68%)
After-hours: Jun 18, 2025, 7:20 PM EDT
2.56%
Market Cap 132.94M
Revenue (ttm) 834.27M
Net Income (ttm) -1.85M
Shares Out 23.74M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,198
Open 5.45
Previous Close 5.46
Day's Range 5.37 - 5.63
52-Week Range 5.37 - 21.00
Beta 1.49
Analysts Hold
Price Target 18.00 (+221.43%)
Earnings Date Aug 7, 2025

About GOCO

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance purchasing behavior to reimagine the process of matching a health plan for a consumer’s specific needs. It also provides Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special needs plans. In addition, the company offers partner marketing services. It sells its products through... [Read more]

Sector Financials
IPO Date Jul 15, 2020
Employees 2,261
Stock Exchange NASDAQ
Ticker Symbol GOCO
Full Company Profile

Financial Performance

In 2024, GoHealth's revenue was $798.89 million, an increase of 8.74% compared to the previous year's $734.67 million. Losses were -$6.59 million, -90.14% less than in 2023.

Financial Statements

Analyst Forecast

According to one analyst, the rating for GOCO stock is "Hold" and the 12-month stock price forecast is $18.0.

Price Target
$18.0
(221.43% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Bragar Eagel & Squire, P.C. Is Investigating GoHealth and Abacus and Encourages Investors to Contact the Firm

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO) and...

Other symbols: ABL
10 days ago - GlobeNewsWire

Bronstein, Gewirtz & Grossman, LLC Is Investigating GoHealth, Inc. (GOCO) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

16 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GoHealth, Inc. (GOCO) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

17 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GoHealth, Inc. (GOCO) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

18 days ago - Accesswire

GoHealth, Inc. (GOCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

20 days ago - Accesswire

GoHealth, Inc. (GOCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

21 days ago - Accesswire

Regulatory Winds & Execution Catalyze GoHealth's Upside

We initiate on GoHealth with a Strong Buy rating based on our view that the market underestimates both regulatory tailwinds and the execution-driven inflection in revenue and profitability. Our $20/sh...

22 days ago - Seeking Alpha

Bronstein, Gewirtz & Grossman, LLC Is Investigating GoHealth, Inc. (GOCO) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

22 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages GoHealth, Inc. (GOCO) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

23 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GoHealth, Inc. (GOCO) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

24 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GoHealth, Inc. (GOCO) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / May 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

27 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating GoHealth, Inc. (GOCO) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

4 weeks ago - Accesswire

GoHealth, Inc. (GOCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GoHealth, Inc. (GOCO) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages GoHealth, Inc. (GOCO) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDA...

4 weeks ago - Accesswire

Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q1

Dallas, Texas--(Newsfile Corp. - May 14, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong firs...

5 weeks ago - Newsfile Corp

GoHealth, Inc. (GOCO) Q1 2025 Earnings Call Transcript

GoHealth, Inc. (NASDAQ:GOCO) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants John Shave - Vice President of Investor Relation Vijay Kotte - Chief Executive Officer Brend...

5 weeks ago - Seeking Alpha

Stonegate Capital Partners Initiates Coverage on GoHealth Inc. (GOCO)

Dallas, Texas--(Newsfile Corp. - March 24, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners initiates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong ...

3 months ago - Newsfile Corp

GoHealth, Inc. (GOCO) Q4 2024 Earnings Call Transcript

GoHealth, Inc. (NASDAQ:GOCO) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants John Shave - Vice President, Investor Relation Vijay Kotte - Chief Executive Officer Br...

4 months ago - Seeking Alpha

GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment Period

CHICAGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announ...

4 months ago - GlobeNewsWire

Kuehn Law Encourages Investors of GoHealth, Inc. to Contact Law Firm

NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoHealth, Inc. (NASDAQ: GOCO) breached their fid...

4 months ago - PRNewsWire

GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025

CHICAGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc.  (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company wil...

4 months ago - GlobeNewsWire

GoHealth: Smart Moves Are Paying Off

GoHealth Inc has put together a string of several quarters with positive operating cash flow on a trailing-twelve month basis, showing clear signs of stabilizing. During the third quarter of 2024, the...

7 months ago - Seeking Alpha

GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript

GoHealth, Inc. (NASDAQ:GOCO) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants John Shave - Vice President, Investor Relation Vijay Kotte - Chief Executive Officer Bre...

7 months ago - Seeking Alpha

GoHealth Reports Third Quarter 2024 Results

CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announ...

8 months ago - GlobeNewsWire